GM-CSF-induced regulatory T cells selectively inhibit anti-acetylcholine receptor-specific immune responses in experimental myasthenia gravis

Journal of Neuroimmunology

Volumn 240-241, Issue , 2011, Pages 65-73

  Sheng, Jian Rong ^a   Muthusamy, Thiruppathi ^a   Prabhakar, Bellur S ^a   Meriggioli, Matthew N ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

Author keywords

Acetylcholine receptor; Autoimmune disease; Experimental autoimmune myasthenia gravis; GM CSF; Myasthenia gravis; Regulatory T cells

Indexed keywords

CHOLINERGIC RECEPTOR ANTIBODY; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; OVALBUMIN; THYROGLOBULIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; DRUG MECHANISM; FEMALE; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOCYTE COUNT; LYMPHOCYTE PROLIFERATION; MOUSE; MYASTHENIA GRAVIS; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE;

ADOPTIVE TRANSFER; ANIMALS; ANTIBODY SPECIFICITY; AUTOANTIBODIES; CELL PROLIFERATION; CHOLINERGIC ANTAGONISTS; DENDRITIC CELLS; FEMALE; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; IMMUNE TOLERANCE; MICE; MICE, INBRED C57BL; MYASTHENIA GRAVIS, AUTOIMMUNE, EXPERIMENTAL; RECEPTORS, CHOLINERGIC; STEM CELLS; T-LYMPHOCYTES, REGULATORY;

EID: 83555178432     PISSN: 01655728     EISSN: 18728421     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2011.10.010     Document Type: Article

References (47)

1. Arellano M., Lonial S. Clinical uses of GM-CSF, a critical appraisal and update. Biologics 2008, 2:13-27.
2. Askenasy N., Kaminitz A., Yarkoni S. Mechanisms of T regulatory cell function. Autoimmun. Rev. 2008, 7:370-375.
3. Banchereau J., Steinman R.M. Dendritic cells and the control of immunity. Nature 1998, 392:245-252.
4. Bhattacharya P., Gopisetty A., Ganesh B., Sheng J.R., Prabhakar B.S. GM-CSF-induced, bone-marrow-derived dendritic cells expand natural Tregs by different mechanisms. J. Leukoc. Biol. 2011, 89:235-249.
5. Bluestone J.A., Abbas A.K. Natural versus adaptive regulatory T cells. Nat. Rev. 2003, 3:253-257.
6. + regulatory T cells control autoimmunity?. Curr. Opin. Immunol. 2005, 17:638-642.
7. Brusko T.M., Putnam A.L., Bluestone J.A. Human regulatory T cells: role in autoimmune disease and therapeutic opportunities. Immunol. Rev. 2008, 223:371-390.
8. Cella M., Scheidegger D., Palmer-Lehmann K., Lane P., Lanzavecchia A., Alber G. Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation. J. Exp. Med. 1996, 184:747-752.
9. Cerutti A., Qiao X., He B. Plasmacytoid dendritic cells and the regulation of immunoglobulin heavy chain class switching. Immunol. Cell Biol. 2005, 83:554-562.
10. Christadoss P., Poussin M., Deng C. Animal models of myasthenia gravis. Clin. Immunol. 2000, 94:75-87.
11. + regulatory T cells suppress effector T cell proliferation. Clin. Immunol. 2005, 115:3-9.
12. + T regulatory cells in myasthenia gravis: effect of immunosuppressive treatment. Immunology 2005, 116:134-141.
13. + regulatory T cell expansion resulting in suppression of autoimmune thyroiditis. Int. Immunol. 2009, 21:269-282.
14. Ganesh B.B., Bhattacharya P., Gopisetty A., Sheng J.R., Vasu C., Prabhakar B.S. IL-1β promotes TGF-β1 and IL-2 dependent FoxP3 expression in regulatory T cells. PLoS One 2011, 6(7):e21949.
15. + regulatory T cells play a critical role in granulocyte-macrophage colony-stimulating factor-induced suppression of experimental autoimmune thyroiditis. J. Immunol. 2005, 174:7006-7013.
16. + regulatory T cells. J. Immunol. 2007, 179:3638-3647.
17. Hamilton J.A. GM-CSF in inflammation and autoimmunity. Trends Immunol. 2002, 23:403-408.
18. high regulatory T cells. Blood 2004, 104:895-903.
19. + regulatory T cells are not mirror images of each other. Trends Immunol. 2008, 29:429-435.
20. + T cells in myasthenia gravis and in relation to thymectomy. Scand. J. Immunol. 2004, 59:408-414.
21. Iikuni N., Lourenço E.V., Hahn B.H., La Cava A. Cutting edge: regulatory T cells directly suppress B cells in systemic lupus erythematosus. J. Immunol. 2009, 183:1518-1522.
22. Langier S., Sade K., Kivity S. Regulatory T cells: the suppressor arm of the immune system. Autoimmun. Rev. 2010, 10:112-115.
23. Lindstrom J.M. Experimental autoimmune myasthenia gravis: induction and treatment. Myasthenia Gravis and Myasthenic Disorders 1999, 111-130. Oxford University Press, New York. A. Engel (Ed.).
24. Lutz M.B., Schuler G. Immature, semi-mature and fully mature dendritic cells: which signals induce tolerance or immunity?. Trends Immunol. 2002, 23:445-449.
25. MacPherson G., Kushnir N., Wykes M. Dendritic cells, B cells and the regulation of antibody synthesis. Immunol. Rev. 1999, 172:325-334.
26. + regulatory T cells and Th17 cells in myasthenia gravis patients. J. Neuroimunol. 2010, 225:123-131.
27. Meriggioli M.N., Sheng J.R., Li L., Prabhakar B.S. Strategies for treating autoimmunity: novel insights from experimental myasthenia gravis. Ann. N. Y. Acad. Sci. 2008, 1132:276-282.
28. Meriggioli M.N., Sanders D.B. Myasthenia gravis: emerging clinical and biological heterogeneity. Lancet Neurol. 2009, 8:475-490.
29. Moes N., Rieux-Laucat F., Begue B., Verdier J., Neven B., Patey N., Torgerson T.T., Picard C., Stolzenberg M.C., Ruemmele C., Rings E.H., Casanova J.L., Piloquet H., Biver A., Breton A., Ochs H.D., Hermine O., Fischer A., Goulet O., Cerf-Bensussan N., Ruemmele F.M. Reduced expression of FOXP3 and regulatory T-cell function in severe forms of early-onset autoimmune enteropathy. Gastroenterology 2010, 139:770-778.
30. + depletion hastens the onset of severe disease in collagen-induced arthritis. Arthritis Rheum. 2003, 48:1452-1460.
31. Moser M., Murphy K.M. Dendritic cell regulation of TH1-TH2 development. Nat. Immunol. 2000, 1:199-205.
32. + regulatory T cells prevent but do not improve experimental myasthenia gravis. J. Immunol. 2010, 185:5656-5667.
33. Parmiani G., Castelli C., Pilla L., Santiami M., Colombo M.P., Rivoltini L. Opposite immune functions of GM-CSF administered as vaccine adjuvant in cancer patients. Ann. Oncol. 2007, 18:226-232.
34. Pulendran B., Banchereau J., Burkeholder S., Kraus E., Guinet E., Chalouni C., Caron D., Maliszewski C., Davoust J., Fay J., Palucka K. Flt3-Ligand and granulocyte colony-stimulating factor mobilize distinct human dendritic cell subsets in vivo. J. Immunol. 2000, 165:566-572.
35. O'Keefe M., Hochrein H., Vremec D., Pooley J., Evans R., Woulfe S., Shortman K. Effects of administration of progenipoietin 1, Flt3 ligand, granulocyte colony-stimulating, and pegylated granulocyte colony-stimulating factor on dendritic cell subsets in mice. Blood 2002, 99:2122-2130.
36. + regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu. Rev. Immunol. 2004, 22:531-562.
37. Seo S.J., Fields M.L., Buckler J.L., Reed A.J., Mandik-Nayak L., Nish S.A., Noelle R.J., Turka L.A., Finkelman F.D., Caton A.J., Erickson J. The impact of T helper and T regulatory cells in the regulation of anti-double-stranded DNA B cells. Immunity 2002, 16:535-546.
38. + regulatory T cells. J. Immunol. 2006, 177:5296-5306.
39. Sheng J.R., Li L., Ganesh B.B., Prabhakar B.S., Meriggioli M.N. Regulatory T cells induced by GM-CSF suppress ongoing experimental myasthenia. Clin. Immunol. 2008, 128:172-180.
40. Torgerson T.R. Regulatory T cells in human autoimmune diseases. Springer Semin. Immunopathol. 2006, 28:63-76.
41. + T cells and suppresses experimental autoimmune thyroiditis. J. Immunol. 2003, 170:5511-5522.
42. high regulatory T-cell function in patients with relapsing-remitting multiple sclerosis is correlated with a reduced frequency of FOXP3-positive cells and reduced FOXP3 expression at the single-cell level. Immunology 2008, 123:79-89.
43. Vincent A. Unraveling the pathogenesis of myasthenia gravis. Nat. Rev. Immunol. 2002, 2:797-804.
44. Yamazaki T., Akiba H., Iwai H., Matsuda H., Aoki M., Tanno Y., Shin T., Tsuchiya H., Pardoll D.M., Okumura K., Azuma M., Yagita H. Expression of programmed death 1 ligands by murine T cells and APC. J. Immunol. 2002, 169:5538-5545.
45. + regulatory T cells suppressing autoantibody production in experimental pemphigus vulgaris. Int. Immunol. 2011, 23:365-373.
46. +CD25hi Tregs in the pathogenesis of myasthenia gravis. Immunol. Lett. 2009, 122:52-57.
47. Zou G.M., Tam Y.K. Cytokines in the generation and maturation of dendritic cells: recent advances. Eur. Cytokine Netw. 2002, 13:186-199.